Laurus Global Equity Management Inc. Buys 7,140 Shares of Integer Holdings Corporation $ITGR

Laurus Global Equity Management Inc. lifted its stake in shares of Integer Holdings Corporation (NYSE:ITGR) by 14.9% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 54,910 shares of the medical equipment provider’s stock after purchasing an additional 7,140 shares during the period. Integer accounts for 4.4% of Laurus Global Equity Management Inc.’s holdings, making the stock its 8th biggest position. Laurus Global Equity Management Inc. owned about 0.16% of Integer worth $6,752,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Congress Asset Management Co. raised its position in Integer by 1.6% during the second quarter. Congress Asset Management Co. now owns 530,807 shares of the medical equipment provider’s stock worth $65,273,000 after acquiring an additional 8,151 shares in the last quarter. Cooke & Bieler LP increased its stake in shares of Integer by 6.3% during the 1st quarter. Cooke & Bieler LP now owns 317,393 shares of the medical equipment provider’s stock worth $37,456,000 after purchasing an additional 18,790 shares during the last quarter. Raymond James Financial Inc. raised its holdings in shares of Integer by 6.9% in the 1st quarter. Raymond James Financial Inc. now owns 307,141 shares of the medical equipment provider’s stock valued at $36,245,000 after purchasing an additional 19,839 shares during the period. Vaughan Nelson Investment Management L.P. acquired a new stake in Integer in the 1st quarter valued at about $33,337,000. Finally, New York State Common Retirement Fund grew its holdings in Integer by 7.4% during the first quarter. New York State Common Retirement Fund now owns 249,847 shares of the medical equipment provider’s stock worth $29,484,000 after purchasing an additional 17,278 shares during the period. 99.29% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

ITGR has been the topic of several research analyst reports. Weiss Ratings restated a “hold (c)” rating on shares of Integer in a research note on Saturday, September 27th. Wells Fargo & Company decreased their target price on Integer from $152.00 to $132.00 and set an “overweight” rating on the stock in a report on Friday, July 25th. Raymond James Financial cut their price target on Integer from $150.00 to $143.00 and set an “outperform” rating for the company in a report on Friday, July 25th. Wall Street Zen raised shares of Integer from a “hold” rating to a “buy” rating in a research report on Saturday, August 30th. Finally, Truist Financial dropped their price objective on shares of Integer from $145.00 to $137.00 and set a “buy” rating on the stock in a research report on Friday, July 25th. One research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and two have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $139.57.

Integer Stock Up 2.1%

ITGR opened at $105.21 on Monday. The stock has a fifty day moving average of $105.65 and a 200-day moving average of $114.03. The company has a market capitalization of $3.69 billion, a P/E ratio of 46.35, a P/E/G ratio of 0.83 and a beta of 0.97. Integer Holdings Corporation has a fifty-two week low of $99.73 and a fifty-two week high of $146.36. The company has a debt-to-equity ratio of 0.72, a quick ratio of 2.18 and a current ratio of 3.41.

Integer (NYSE:ITGR) last released its quarterly earnings results on Thursday, July 24th. The medical equipment provider reported $1.55 EPS for the quarter, missing analysts’ consensus estimates of $1.57 by ($0.02). The business had revenue of $476.00 million for the quarter, compared to the consensus estimate of $464.37 million. Integer had a return on equity of 12.27% and a net margin of 4.61%.Integer’s revenue was up 11.4% compared to the same quarter last year. During the same period in the prior year, the business posted $1.30 earnings per share. Integer has set its FY 2025 guidance at 6.250-6.510 EPS. On average, equities analysts expect that Integer Holdings Corporation will post 6.01 EPS for the current year.

Integer Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.